Board of Directors
The N2 Board of Directors consists of 12 individuals representing the different stakeholders within N2 membership.
Karen Arts
Co-founder
Executive Director Canadian Cancer Clinical Trials Network (3CTN)
Jim Pankovich
Chair
Vice President, Clinical Operations & Drug Development-Qu Biologics Inc.
Rachel Syme
Vice Chair
Assistant Director, Institute of Cancer Research, CIHR
Patrick Clifford
Treasurer
Director of Research and Innovation, CreateIT Now @ Southlake Innovation Centre – The Research Institute at Southlake
Erin Cherban
Secretary
Chief Research Officer Centre for Health Evaluation & Outcome Sciences (CHÉOS), CIHR Canadian HIV Trials Network (CTN)
Linda Bennett
Board Member
Project Manager, Marvelle Koffler Breast Centre Research Program
Kathy Brodeur-Robb
Board Member
Executive Director C-17 Council
Lisa Johnston
Board Member
Clinical Research Facilitator, Ottawa Hospital Research Institute (OHRI)
Tammy Mah-Fraser
Board Member
Director, Platform Operations – Alberta Innovates – Health Solutions
Janette Panhuis
Board Member
Chief Operating Officer of the Population Health Research Institute, A Joint Institute of HHS and McMaster University